Ergoteles LLC Adma Biologics, Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $60,721 - $82,129	19,462 New	19,462 $71,000
Q2 2022 Aug 12, 2022	SELL	$1.43 - $2.2 $102,102 - $157,080	-71,400 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.28 - $1.83 $91,392 - $130,662	71,400 New	71,400 $131,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $338,434 - $494,175	-299,500 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$1.51 - $2.07 $452,245 - $619,965	299,500 New	299,500 $479,000
Q1 2021 May 12, 2021	SELL	$1.67 - $2.95 $50,267 - $88,795	-30,100 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$1.8 - $2.56 $54,180 - $77,056	30,100 New	30,100 $59,000

329

192M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.07B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.